Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial
Top Cited Papers
- 1 July 2011
- journal article
- research article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 100 (1), 86-92
- https://doi.org/10.1016/j.radonc.2011.05.013
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Estimation of an Optimal Utilisation Rate for Palliative Radiotherapy in Newly Diagnosed Cancer PatientsClinical Oncology, 2010
- Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphomaAnnals Of Oncology, 2008
- Radiotherapy Dose Fractionation, Access and Waiting Times in the Countries of the UK in 2005Clinical Oncology, 2007
- Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelinesRadiotherapy and Oncology, 2006
- Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphomaBlood, 2006
- High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent LymphomasJournal of Clinical Oncology, 2003
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998
- Low dose palliative radiotherapy in low grade non-Hodgkin's lymphomaRadiotherapy and Oncology, 1997
- Potential role for low dose limited‐field radiation therapy (2 × 2 grays) in advanced low‐grade non‐Hodgkin's lymphomasHematological Oncology, 1994
- CLASSIFICATION OF NON-HODGKIN'S LYMPHOMASThe Lancet, 1974